Sunday, March 4, 2012

New Lung Cancer Study Results Reported from University of Fudan.(Report)

Researchers detail in "Meta-analysis of the relationship between p21 Ser31Arg polymorphism and lung cancer susceptibility," new data in Lung Cancer. "The cyclin-dependent kinase inhibitor 1A (also known as p21) is thought to be involved in tumor development by mediating cell cycle arrest through the inhibition of cyclin/CDK activity. To explore the relationship of Ser31Arg polymorphism in the p21 gene with the risk of developing lung cancer, we performed an overall and stratified meta-analysis based on ethnicity, lung cancer subtypes and source of controls, with six eligible studies (2366 cases and 3320 controls)," researchers in Shanghai, People's Republic of China report (see also …

No comments:

Post a Comment